✦ LIBER ✦

Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients

✍ Scribed by Nicolás Merchante; Ignacio de los Santos-Gil; Dolores Merino; Mercedes González-Serrano; José A. Mira; Jesús Sanz-Sanz; Elisa Fernández-Fuertes; Josefa Ruiz-Morales; José del Valle; Juan Macías; Antonio Moro; Juan A. Pineda

Book ID: 116651773
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 171 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2008.10.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

603 Insulin resistance in co-infected HC

603 Insulin resistance in co-infected HCV/HIV patients: A negative factor influencing sustained response to peginterferon plus ribavirin

✍ M. Romero-Gomez; C. Tural; R. Sola; M.C. Martinez-Sierra; M.M. Viloria; M.D. Jim 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Insulin resistance and HCV virologic res

Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients

✍ C. Donato; A. Cingolani; C. Pinnetti; A. De Luca 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Incidence of anaemia and impact on susta

Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin

✍ M. Núñez; A. Ocampo; K. Aguirrebengoa; M. Cervantes; A. Pascual; S. Echeverria; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

[591] IMPACT OF ANEMIA AND ZIDOVUDINE US

[591] IMPACT OF ANEMIA AND ZIDOVUDINE USE ON SUSTAINED VIROLOGICAL RESPONSE IN A TRIAL OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

✍ M. Nunez; M. Romero; A. Ocampo; K. Aguirrebengoa; M. Cervantes; A. Pascual; S. E 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB

508 Insulin resistance, fibrosis and gen

508 Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C

✍ M. Romero-Gomez; M.M. Viloria; R. Corpas; M. Cruz; D. Sanchez-Munoz; L. Grande; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

The use of different Peg-interferon α-2b

The use of different Peg-interferon α-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response

✍ N. Napoli; G. Giannelli; A. Antonaci; S. Antonaci 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB